Even after adjusting for age, sex, and amyloid positivity, plasma NfL and GFAP remained significantly associated with kidney impairment, suggesting that the influence of kidney dysfunction should be considered when assessing neuronal injury and astrocyte activation in patients with AD. The gene discussed is NEFL; the disease is Alzheimer disease.